Diclofenac vs. Ibuprofen: Which Is Better for Pain?

Diclofenac tends to edge out ibuprofen for raw pain-relieving power, particularly at higher prescription doses, but ibuprofen carries a more favorable safety profile for the heart and gut at the doses most people actually use. A large network meta-analysis published in The Lancet called diclofenac 150 mg/day “the most effective NSAID available at present” for osteoarthritis pain and physical function. Yet that same dose comes with cardiovascular risks that make many clinicians reach for ibuprofen first when the patient has any heart-related concerns. So “which is better” is really a question about what you’re treating, how long you need the drug, and what risks matter most for your body.

How They Compare for Acute Pain

When you twist an ankle, get a tooth pulled, or throw out your back, what you care about is how fast the pain drops and how much relief you get. A systematic review pooling data from dozens of post-operative pain trials found that diclofenac 50 mg and ibuprofen 400 mg performed similarly in direct head-to-head comparisons, with no statistically significant difference between the two.¹ Both drugs worked well against placebo, and the authors concluded that choosing between them for a single episode of acute pain comes down to dose, safety, and cost rather than a meaningful gap in efficacy.

One area where diclofenac may have a slight advantage is dental pain lasting several hours. A trial comparing diclofenac potassium, ibuprofen, and paracetamol after tooth extractions found that diclofenac produced significantly lower pain scores at four and six hours after the procedure.² Diclofenac potassium, the fast-dissolving salt used in many over-the-counter formulations, reaches peak blood levels in about 30 minutes, which helps explain why it can feel like it kicks in quickly for sharp, localized pain.

Chronic Joint Pain and Osteoarthritis

For ongoing conditions like osteoarthritis or rheumatoid arthritis, where you need weeks or months of relief rather than a few hours, the calculus shifts. A network meta-analysis covering 146 studies and over 100,000 patients concluded that diclofenac at 150 mg/day was the most effective NSAID for both pain relief and physical function in osteoarthritis.³ A separate meta-analysis looking at both osteoarthritis and rheumatoid arthritis found that diclofenac 150 mg/day was likely more effective than ibuprofen 2400 mg/day for pain, though at the lower dose of 100 mg/day, diclofenac was comparable to most other options.⁴

That said, not every trial hands the crown to diclofenac. One older comparative trial of sustained-release formulations found that once-daily ibuprofen 1600 mg actually outperformed once-daily diclofenac on several measures, including investigator-rated improvement and patient-reported relief of night pain and daytime activity.⁵ Formulation matters: a slow-release tablet delivering steady blood levels throughout the day can outperform a standard tablet of a theoretically stronger drug. The practical takeaway is that while diclofenac at full prescription doses has the strongest evidence for osteoarthritis on average, ibuprofen in the right formulation remains a legitimate competitor.

Menstrual Pain

Period cramps are driven by prostaglandins that cause the uterus to contract, which makes them a textbook target for NSAIDs. A network meta-analysis of over-the-counter analgesics for menstrual pain ranked diclofenac first and ibuprofen a very close second, with probability scores of about 85% and 84% respectively for being the most effective option.⁶ A broader network meta-analysis that included prescription-strength NSAIDs found diclofenac and ibuprofen performing similarly to each other, both well ahead of aspirin.⁷

A direct head-to-head trial of diclofenac dispersible 50 mg against ibuprofen 400 mg for menstrual pain showed nearly identical total pain relief scores over six hours, with ibuprofen actually edging slightly ahead numerically.⁸ For most people dealing with period pain, either drug at standard OTC doses will work about equally well, and the choice often comes down to whichever you tolerate better or have on hand.

Why They Work Differently Under the Hood

Both diclofenac and ibuprofen belong to the same drug class, but they interact with the body’s inflammation pathways in meaningfully different ways. The enzymes they target, COX-1 and COX-2, do different jobs. COX-2 drives inflammation and pain. COX-1 helps protect the stomach lining and supports platelet function. A study measuring enzyme inhibition in healthy volunteers found that diclofenac blocked about 94% of COX-2 but only about 50% of COX-1, while ibuprofen blocked roughly 71% of COX-2 and 89% of COX-1.⁹

In plain terms, diclofenac is a much more selective COX-2 inhibitor. It zeroes in on the inflammation enzyme without shutting down as much of the stomach-protecting enzyme. That selectivity is actually comparable to celecoxib, a drug specifically designed and marketed as a COX-2 inhibitor.¹⁰ This distinction matters because it ripples through every major safety consideration: it’s why diclofenac is gentler on the stomach in some respects, but it also explains the cardiovascular concern that shadows the drug.

Cardiovascular Risk

This is where the comparison turns serious, and where diclofenac’s COX-2 selectivity becomes a liability rather than an asset. COX-2-selective drugs tip the balance of prostaglandins in the blood toward clotting and vessel constriction, which raises the risk of heart attacks, strokes, and cardiovascular death. A large Danish nationwide cohort study found that starting diclofenac raised the rate of major cardiovascular events by about 50% compared with not taking any NSAID, and by about 20% compared with starting ibuprofen or paracetamol.¹¹ That increased risk showed up even at low doses and included heart attack, stroke, heart failure, and cardiac death.

Ibuprofen is not risk-free either. A network meta-analysis of 31 large trials found that ibuprofen carried the highest point estimate for stroke risk among the NSAIDs studied, while diclofenac was associated with the highest risk of cardiovascular death.¹² A position paper from the European Society of Cardiology reviewed the large meta-analyses and noted that both high-dose diclofenac and high-dose ibuprofen were linked to increased vascular events, while naproxen consistently appeared neutral.¹³

The bottom line for your heart: if you have existing cardiovascular disease, a history of heart attack or stroke, or multiple risk factors, diclofenac is generally the worse choice of the two, and many guidelines recommend avoiding it entirely in that population. Ibuprofen at OTC doses (up to 1200 mg/day) appears to carry less cardiovascular risk than diclofenac, though it is still not as neutral as naproxen.

Gastrointestinal Safety

Stomach problems are the most common reason people stop taking NSAIDs. Both drugs can cause nausea, heartburn, and ulcers, but ibuprofen generally has a lighter footprint at typical doses. A systematic review and meta-analysis of GI bleeding risk found that among non-selective NSAIDs, ibuprofen had the lowest significant risk, with an odds ratio of about 2.3 compared to non-users.¹⁴ Diclofenac’s risk for upper GI bleeding was also documented, with one large study finding that both ibuprofen and diclofenac raised the risk of upper GI bleeding but not lower GI bleeding.¹⁵

You might expect diclofenac’s COX-2 selectivity to spare the stomach, and there is some logic to that since COX-1 is the enzyme that maintains the stomach’s protective mucus layer. But in practice, the GI advantage of diclofenac over ibuprofen is modest at best. An older Lancet analysis of individual NSAIDs and upper GI risk found that all the major NSAIDs, including both ibuprofen and diclofenac, had relative risks broadly similar to the overall NSAID class average.¹⁶ If you’re at elevated risk for GI complications, a proton pump inhibitor taken alongside either NSAID can help. A study of diclofenac users found that adding a PPI reduced the risk of hospitalization for peptic ulcer disease by about 60%.¹⁷ That said, long-term PPI use comes with its own set of concerns, so this strategy works best as a deliberate, time-limited approach rather than a permanent habit.¹⁸

Who Is at Highest Risk for GI Problems

A systematic review of clinical guidelines identified several established risk factors for gastrointestinal complications with any NSAID. The factors considered definite include a history of peptic ulcer disease, older age (guidelines set the cut-off somewhere between 60 and 75 depending on the source), concurrent use of blood thinners or corticosteroids, and taking more than one NSAID at a time, including low-dose aspirin.¹⁹ If you fall into any of those categories, both ibuprofen and diclofenac require extra caution, and the choice between them matters less than the decision about whether to use an oral NSAID at all versus a topical option or a different drug class.

Topical Gels and Creams

One way to sidestep most of the systemic risk of oral NSAIDs is to rub the drug directly onto the painful area. Both diclofenac and ibuprofen are widely available as topical gels, and this is where the comparison gets interesting. A lab study measuring how well each drug penetrates skin found that ibuprofen formulations permeated more rapidly and in greater quantities, but diclofenac produced higher calculated anti-inflammatory activity at the tissue level.²⁰ In other words, diclofenac doesn’t need to get as much drug through the skin because it is more potent once it arrives.

A clinical trial comparing the two gels for musculoskeletal injuries found that diclofenac gel and an ibuprofen gel with added levomenthol (a cooling agent) both reached meaningful pain relief in about 20 minutes, while plain ibuprofen gel took closer to 25 minutes and produced less overall relief.²¹ Topical diclofenac, sold as Voltaren gel in many countries, has become one of the most popular OTC pain products. Its advantage is that very little drug reaches the bloodstream, dramatically reducing the cardiovascular and GI risks that come with oral tablets.

Dosing and Over-the-Counter Access

Availability differs by country, and this shapes how most people actually encounter these drugs. In most markets, OTC ibuprofen tops out at 1200 mg per day (typically three 400 mg doses), while OTC diclofenac is capped at 75 mg per day (usually three 25 mg doses).²² Prescription doses go considerably higher: up to 2400 mg/day for ibuprofen and 150 mg/day for diclofenac. The efficacy advantages that show up in the large meta-analyses tend to reflect those higher prescription doses, not the OTC doses most people buy at the pharmacy.

At OTC strengths, the gap between the two drugs narrows considerably. Diclofenac potassium at 25 mg per tablet, the standard OTC dose in many countries, has been shown to be at least as effective as ibuprofen 400 mg for a single episode of pain. For everyday aches, where you’re taking two or three tablets over a day or two, either drug at OTC doses will often do the job.

Interactions With Blood Thinners and Aspirin

If you take warfarin or another anticoagulant, both ibuprofen and diclofenac deserve extra caution. All NSAIDs interfere with platelet function and can trigger GI bleeding, both of which become more dangerous when an anticoagulant is already thinning the blood.²³ Combining the two is generally discouraged, and when it’s unavoidable, the shortest possible course at the lowest effective dose is the standard advice.

There’s an additional wrinkle for people taking low-dose aspirin to protect their heart. Ibuprofen can block aspirin from reaching the COX-1 enzyme on platelets, potentially undermining aspirin’s anti-clotting benefit. Diclofenac, with its lower COX-1 inhibition, may interfere less with aspirin’s action, though the safest approach if you need both is to take aspirin first and wait at least 30 minutes before taking ibuprofen. If you’re on daily aspirin therapy and need regular NSAID use, this is a conversation to have with your doctor rather than something to manage on your own.

Liver Concerns

NSAIDs as a class can occasionally cause liver injury, though the incidence is low. Review data places the rate of NSAID-induced liver disease somewhere between fewer than 1 and 9 cases per 100,000 users, with hospitalizations slightly higher. Diclofenac has historically drawn more attention for liver effects than ibuprofen, and in some countries product labels require liver function monitoring during prolonged use. These events remain rare, but if you already have liver disease or drink heavily, the risk tilts toward avoiding diclofenac in favor of lower-risk alternatives.

NSAIDs and Tissue Healing After Injury or Surgery

A common worry among athletes and surgeons is that anti-inflammatory drugs might slow the healing of muscles, tendons, or bones. A review of the evidence found insufficient proof that standard-dose NSAIDs or COX-2 inhibitors harm soft tissue healing when used for two weeks or less.²⁴ For bone healing, the picture is murkier: indomethacin showed a clear negative effect, while evidence for other NSAIDs was less convincing. A more recent systematic review of knee surgeries found that neither non-selective COX inhibitors nor selective COX-2 inhibitors caused a significant increase in failure of ACL reconstructions or meniscal repairs.²⁵

The practical advice: short courses of either ibuprofen or diclofenac after a sprain or minor surgery are unlikely to cause healing problems. If you’re recovering from a fracture or a procedure where bone fusion is critical, your surgeon will typically steer you away from NSAIDs regardless of which one it is.

Pregnancy and Nursing

Neither drug is considered safe in the third trimester of pregnancy, when NSAIDs can cause premature closure of a vessel in the fetal heart. Earlier in pregnancy, data is limited but not entirely reassuring. A large prospective cohort study found that second-trimester ibuprofen use was linked to a higher risk of low birth weight, and use in the second or third trimester was associated with asthma in the child at 18 months. Second-trimester diclofenac use was also associated with low birth weight, and third-trimester use with maternal vaginal bleeding. Neither drug was linked to congenital malformations or structural heart defects in that study.²⁶ The safest default during pregnancy is to avoid both drugs unless your doctor specifically recommends one for a short period in the first or early second trimester.

Allergic and Hypersensitivity Reactions

NSAIDs are the second most common cause of drug hypersensitivity reactions after penicillin-type antibiotics. These reactions can affect the skin (hives and swelling), the airways (worsened asthma, nasal polyp flare-ups), or in rare cases trigger full anaphylaxis. Because both diclofenac and ibuprofen block COX-1 to some degree, either can provoke these reactions in susceptible people. However, since ibuprofen inhibits COX-1 more aggressively, individuals with aspirin-exacerbated respiratory disease tend to react more strongly to ibuprofen. If you’ve ever had hives, swelling, or breathing difficulty after taking aspirin or any NSAID, you should treat both drugs with caution and discuss alternatives with a doctor.

Environmental Footprint

An angle most people don’t think about when choosing a painkiller is what happens after the drug leaves your body. Both diclofenac and ibuprofen end up in waterways through sewage, and both are toxic to aquatic life. A review of ecotoxicology data found that certain freshwater crustaceans and amphipods were particularly sensitive to diclofenac, even though ibuprofen has been studied more extensively across aquatic species.²⁷ Diclofenac has received particular regulatory attention in parts of Europe and South Asia, where it was linked to catastrophic declines in vulture populations that fed on livestock carcasses containing the drug. That problem is specific to veterinary use and livestock dosing, not human consumption, but it illustrates that diclofenac is a more environmentally persistent compound than ibuprofen in many ecosystems. For any individual’s pill-by-pill choice, this is a minor factor. But at a population level, it has shaped drug policy in several countries.

Matching the Drug to the Person

Expert panels that develop NSAID guidelines emphasize that the choice between drugs like diclofenac and ibuprofen should be driven by the patient’s overall risk profile rather than by a blanket ranking of which drug is “stronger.”²⁸ The decision tree looks roughly like this:

• Low cardiovascular risk, no GI history: Either drug works. Diclofenac may offer slightly better pain relief at prescription doses for chronic conditions.
• Elevated cardiovascular risk: Ibuprofen at the lowest effective dose, or naproxen, is preferred. Diclofenac is generally avoided.
• History of stomach ulcers or GI bleeding: A topical NSAID or a different drug class is the safest route. If an oral NSAID is essential, ibuprofen at OTC doses with a short course of PPI co-therapy is a common approach.
• On blood thinners: Avoid both if possible. If needed, use the lowest dose for the shortest time, and consider topical formulations.
• Localized pain (knee, hand, ankle): Topical diclofenac gel is often the best first step, delivering meaningful relief with minimal systemic exposure.

For a healthy person dealing with occasional pain, the honest answer is that both drugs work well and the differences are small enough that convenience and personal tolerance often decide. If you find that one upsets your stomach and the other doesn’t, that’s a perfectly valid reason to stick with the one that agrees with you. The safety differences become more important the longer you take the drug and the more medical baggage you carry.